
YZi Labs Responds to Adoption of Poison Pill and Defensive Bylaw Amendments by CEA Industries
Expresses Disappointment in the Board's Apparent Focus on Entrenchment Rather Than Stockholder Interests Calls on the Board to Avoid Further Manipulative Behavior and to Guarantee a Free and Fair Director Nomination and Election Process Rejects False Claim that the Company Has Never Considered Alternative Tokens ROAD TOWN, British Virgin Islands, Jan. 05, 2026 (GLOBE NEWSWIRE) -- YZILabs Management Ltd. (“YZi”, “we”, “our”), a significant stockholder of CEA Industries Inc. (NASDAQ: BNC) (“BNC” or the “Company”), is reviewing the recent actions taken by BNC in response to YZi's group formation and launch of a consent solicitation process.


















